Skip to content

Comparison of High- and Low-Energy Laser Therapy in Patients with Knee Osteoarthritis

Comparative Effects of High-Energy and Low-Energy Laser Therapy on Clinical Outcomes and Neuromuscular Function in Patients with Knee Osteoarthritis (HELLO-KOA Trial) - Comparative Effects of High-Energy and Low-Energy Laser Therapy on Clinical Outcomes and Neuromuscular Function in Knee Osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000060248
Enrollment
60
Registered
2026-01-03
Start date
2024-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis (KOA)

Interventions

Participants will receive high energy laser therapy targeting the painful knee region. The intervention will be delivered using a high energy laser device with a maximum output power of up to 30 W, em
=15 mm will be used to address deep pain and inflammatory tissues. Each session will be conducted under standardized parameters for treatment duration and frequency, consistent with the study protocol

Sponsors

Qufu Normal University, Qufu, Shandong, China
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adults aged 50 to 75 years. Clinical diagnosis of knee osteoarthritis according to established criteria (e.g., American College of Rheumatology criteria). Presence of chronic knee pain for at least 3 months, with a pain intensity >= 40 mm on a 0 to 100 mm Visual Analogue Scale (VAS) at baseline. Radiographic evidence of knee osteoarthritis classified as Kellgren Lawrence grade II to III. Ability to walk independently without assistive devices. No participation in other physical therapy, laser therapy, or injection treatments for knee pain within the previous 3 months. Willingness to comply with the intervention protocol and assessment schedule. Provision of written informed consent prior to participation.

Exclusion criteria

Exclusion criteria: Prior knee surgery, knee replacement, or major lower limb surgery within the past 12 months. Inflammatory arthritis (e.g., rheumatoid arthritis, gout) or other systemic musculoskeletal or neurological disorders affecting lower limb function. Severe knee osteoarthritis (Kellgren Lawrence grade IV). Intra-articular injection, systemic corticosteroid use, or physical therapy for knee pain within the previous 3 months. Contraindications to laser therapy, including malignancy, photosensitivity disorders, pregnancy, or implanted electronic medical devices. Skin infection, open wound, or dermatological conditions at the treatment site. Inability to comply with the intervention protocol or outcome assessments.

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study is the change in overall clinical effectiveness, assessed by knee pain intensity using the Visual Analogue Scale (VAS). Pain levels will be measured at baseline and after completion of the intervention period to compare the therapeutic effects of high-energy laser therapy and low-energy laser therapy in individuals with knee osteoarthritis.

Secondary

MeasureTime frame
The secondary outcomes include changes in neuromuscular function and postural performance. Specifically, lower-limb muscle stiffness will be assessed using ultrasound-based elastography, muscle co-activation patterns will be evaluated using surface electromyography during functional tasks, and balance control will be assessed using standardized balance tests. All secondary outcomes will be measured at baseline and after the intervention period to compare the additional effects of high-energy and low-energy laser therapy.

Countries

Asia(except Japan)

Contacts

Public ContactPing Liu

Qufu Normal University College of Physical Education and Sport Science

liu2578794@gmail.com+8613639443653

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026